DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Dutasteride
Dutasteride
Nonsurgical Hair Restoration Treatment
Health Risks Associated with Long-Term Finasteride and Dutasteride Use: It’S Time to Sound the Alarm
Hormonal Treatment Strategies Tailored to Non-Binary Transgender Individuals
Gender-Affirming Hormone Therapy
Basics of Hormone Therapy for Transgender Patients Julie K
Risk of Depression After 5 Alpha Reductase Inhibitor Medication: Meta-Analysis
Endocrine Therapy for Transgender Youth
Pharmacologic Basis for the Enhanced Efficacy of Dutasteride Against Prostatic Cancers Yi Xu, Susan L
An Analysis on Whether Or Not Baldness Can Be Reversed
Hormonal Therapies for Hidradenitis Suppurativa: Review
Efficacy and Tolerability of the Dual 5A-Reductase Inhibitor, Dutasteride, in the Treatment of Benign Prostatic Hyperplasia in African-American Men
Androgens in Women: Hormone-Modulating Therapies For
Role of Dutasteride in Preclinical ETS Fusionpositive Prostate Cancer Models
Protocols for the Provision of Hormone Therapy Table of Contents
An Evidence-Based Approach to Understanding the Pharmacological Class Effect in the Management of Prostatic Diseases
An Open-Label Prospective Observational Study of Antiandrogen and Non-Antiandrogen Early Pharmacological Approaches in Females with Mild-To-Moderate COVID-19
Interpretation of Serum PSA in Men Taking 5, Alpha Reductase Inhibitors
Hair-Loss-Handouts-180916
Top View
Dutasteride and Finasteride for Men with Benign Prostatic Hyperplasia: Comparative Clinical Effectiveness and Safety
Prostate Cancer Patients Can Benefit from 5-Alpha-Reductase
Reductase Inhibitor Dutasteride on Localized Prostate Cancer Results from a 4-Month Pre-Radical Prostatectomy Study
The AVOCAT Study
Medical Management of Gender Transition
For Benign Prostatic Hyperplasia STEPHEN A
Avodart) Reference Number: ERX.NPA.26 Effective Date: 09.01.17 Last Review Date: 08.17 Line of Business: Commercial [Prescription Drug Plan] Revision Log
Phase I-II Trial of Weekly Bicalutamide in Men with Elevated Prostate-Specific Antigen and Negative Prostate Biopsies
Phase II Study of Androgen Synthesis Inhibition with Ketoconazole
Dutasteride Reduces Viral Shedding, in Ammatory
New Zealand Data Sheet 1
In the Treatment of Patients with Prostate Cancer
PROPECIA Safely and Effectively
Eighty Years of Targeting Androgen Receptor Activity in Prostate Cancer: the Fight Goes On
Guidelines for the Primary and Gender-Affirming Care of Transgender and Gender Nonbinary People
Hirsutism Acne and Hair Loss Management Of
Hair Loss in Women
AVODART 3 (Dutasteride) 4 Soft Gelatin Capsules
Pil.11310.Pdf
Androgen Regulates SARS-Cov-2 Receptor Levels and Is Associated with Severe COVID-19 Symptoms in Men
Dutasteride. AVODART
Australian Public Assessment Report for Dutasteride/Tamsulosin
Dutasteride 0.5 Mg Capsules, Soft Dutasteride
Basal Cell Proliferation Induced by Chlormadinone Acetate Suggests Stem Cell Transformation of Prostatic Cells
Gender Affirming Hormone Therapy Prescriber Guidelines
Dutasteride 0.5 Mg Soft Capsules Dutasteride
Dutasteride (Avodart)
M08: Evaluation and Management of Hirsutism David A
AVODART (Dutasteride) Soft Gelatin Capsules ------WARNINGS and PRECAUTIONS ------Initial U.S
National PBM Drug Monograph Dutasteride (Avodart™) March 2003
The Effects of Chlormadinone Acetate on Lower Urinary Tract
Pharmacogenetic Analysis of Human Steroid 5Α Reductase Type II
Sexual Side Effects of 5-Α-Reductase Inhibitors Finasteride and Dutasteride
In Vitro and in Vivo Assessment of Metabolic Drug Interaction Potential of Dutasteride with Ketoconazole
Blood Loss and Postoperative Complications Associated With
Treatment of Female Pattern Hair Loss with Combination Therapy Rosalynn R Z Conic, MD1,2; Shilpi Khetarpal, MD1; and Wilma Bergfeld, MD1
Hormone Therapy for Prostate Cancer – a Patient Guide
Dutasteride-Tamsulosin Hydrochloride Glenmark 0.5 Mg-0.4 Mg Hard
The Continuing Debate of 5-Alpha Reductase Inhibitors and Prostate Cancer Risk
Hormone Therapy & Prostate Cancer: a Patient Guide